Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SDS Optic

Explore full profile

First ever European based cutting-edge medical DeepTech connecting molecular biology with novel photonics technologies, chemistry & biomedical engineering

Lublin, PolandFounded 2013Biotech & Life Sciences
Valuation $15M Market cap · 2022
Revenue $1.1M Latest reported FY

About SDS Optic

SDS Optic is a pioneering startup specializing in advanced medical diagnostics. The company has developed a cutting-edge technology called inPROBE, which focuses on the rapid and highly accurate detection of substances in the body, such as cancer markers. This technology leverages laser beams and innovative components to identify and measure these substances with exceptional precision. The results are then processed through a specialized algorithm, converting the data into numerical values that indicate the levels of the tested compounds, such as the HER2 cancer marker.

Read full description

SDS Optic primarily serves healthcare providers, including hospitals, clinics, and research institutions, who require precise and quick diagnostic tools to improve patient outcomes. The company operates in the medical diagnostics market, which is a rapidly growing sector driven by the increasing demand for early and accurate disease detection.

The business model of SDS Optic revolves around the development, production, and sale of its inPROBE technology. The company generates revenue by selling these diagnostic devices to healthcare providers and possibly through licensing agreements with other medical technology firms. Additionally, SDS Optic may offer maintenance and support services for its products, providing an ongoing revenue stream.

In summary, SDS Optic is at the forefront of medical diagnostics innovation, offering a highly sensitive and rapid detection technology that can significantly enhance the accuracy of disease markers identification. This positions the company as a valuable player in the healthcare industry, catering to the needs of medical professionals and institutions seeking reliable diagnostic solutions.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2013
Headquarters
Lublin, Poland
Listing
IPO 2022
Sector
Biotech & Life Sciences

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • The National Centre for Research and Development
  • PFR Ventures
  • European Innovation Council

Series A2 investors entered at this stage

  • Aniołowie Biznesu
  • Wschodnia Sieć

Series B and later2 investors entered at this stage

  • INNOventure
  • European Investment Bank
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇵🇱 Poland88.2%
🇺🇸 United States11.8%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SDS Optic on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SDS Optic on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.